CVS Health is slowly righting the ship after several challenging years. Abbott Laboratories’ strong business should improve thanks to an acquisition.
Source: https://www.fool.com/investing/2025/12/18/2-dividend-stocks-…
The 8 “big and rich” tech stocks ARE the stock market (37% of the S&P 500), but indexation reduces long-term stock-picking value. My technical analysis of these is thus for shorter-term, tactical trading, viewing the giants as too overvalued for long-term holding.
Broadcom has a massive opportunity ahead with custom AI chips. UiPath has huge potential upside as its revenue starts to accelerate.
Analysts are making no secret about the S&P 500 stocks they think you should avoid next year. But they have their favorites, too.
